Evaluation of CBT in older persons with anxiety: a pilot study

Not Applicable

Completed

Conditions: Mental and Behavioural Disorders: Anxiety disorders
Mental and Behavioural Disorders
Anxiety disorders

Registration Number: ISRCTN55236453

Lead Sponsor: Department of Health

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: Not specified

Target Recruitment: 20

Inclusion Criteria

1. Diagnosis of generalised anxiety disorder, panic with or without moderate depression
2. Have the capacity to give informed consent
3. Have a sufficient level of literacy in order to use the materials provided during the course
4. Have a maximum score of no more than 29 (a score of 30 plus indicates severe depression) on the Beck Depression Inventory 1 (Beck et al 1986)
5. Any current physical health problems are stable and expected to be stable for the duration of the trial

Exclusion Criteria

1. Clinical diagnosis of an organic brain syndrome including dementia as assessed by their consultant
2. Severe sensory impairment that could prevent use of the material provided during the course
3. Non-English speaking
4. Should participants experience a significant change in their physical health during the trial they may continue with the trial if they wish, but their data will be excluded from the analysis.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The following measures will be used:<br>Penn State Worry Questionnaire (Meyer et al 1990)<br>Beck Anxiety Inventory (BAI) Beck et al (1988)<br>Beck Depression Inventory 1 (BDI) Beck et al (1986)<br><br>Outcome measures will be completed pre and post treatment, and at one month and six month intervals after completion of treatment. All groups (intervention and control in both settings) will complete measures at the same times. The member of research staff responsible for collection and completion of the measures will be blind to the participant?s status within the trial.

Secondary Outcome Measures